
Hoping rosuvastatin for primary prevention of cardiovascular events, are all statins similar and are we ready for statinizing the globe?
June 27, 2016Arun H. S. KumarEditor in Chief, Journal of Natural Science, Biology and Medicine, University College Dublin, Dublin, Ireland.DOI: 10.4103/0976-9668.184694 ABSTRACT Earlier this year the results from Heart Outcomes Prevention Evaluation (HOPE-3) trial were published, which strongly supported the potential use of rosuvastatin…